A comprehensive view of Respiratory / Lung Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Pulp & Paper Industry Market Intelligence Service.
CHMP recommends EU approval of Roche’s Alecensa monotherapy as the first adjuvant treatment for resected ALK-positive early-stage lung cancer; about half of people living with early-stage NSCLC experiencing disease recurrence or death following surgery
Published:
April 26, 2024
by F. Hoffmann-La Roche Ltd. (Roche)
|
Novavax Prepared to Deliver Protein-based Non-mRNA JN.1 COVID-19 Vaccine in Line with WHO Recommendation this Fall
Published:
April 26, 2024
by Novavax Inc.
|
Sanofi to showcase new data on potential respiratory disease treatments at the American Thoracic Society International Conference in San Diego, California, May 17-22; Sanofi to present 25 abstracts across approved and investigational medicines
Published:
April 26, 2024
by Sanofi SA
|
BRISTOL MYERS SQUIBB CO - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published:
April 25, 2024
by SEC Edgar Filings
|
European Patent Office Publishes Eli Lilly and Company's Patent Application for 2019 Novel Coronavirus Antibody-Containing Pharmaceutical Formulations
Published:
April 25, 2024
by Pharmaceutical Patent News
|
Ask us about our Pulp & Paper Industry market view